Biodesix, Inc.
US ˙ NasdaqGM ˙ US09075X1081

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for John Patience. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at John Patience har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:BDSX / Biodesix, Inc. Director 407.486
US:AXDX / Accelerate Diagnostics, Inc. Director 653.224
US:SRCL / Stericycle, Inc. Director 3.878
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af John Patience. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb BDSX / Biodesix, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BDSX / Biodesix, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-11-05 BDSX PATIENCE JOHN 75.000 1,3828 3.750 27,6560 103.710 314 7.6000 -75.210 -72,52
2022-11-21 BDSX PATIENCE JOHN 1.739.130 1,1500 86.956 23,0000 2.000.000
2022-04-07 BDSX PATIENCE JOHN 279.329 1,7900 13.966 35,8000 499.999
2021-12-30 BDSX PATIENCE JOHN 137.931 4,3500 6.897 87,0000 600.000
2021-12-30 BDSX PATIENCE JOHN 22.988 4,3500 1.149 87,0000 99.998
2021-11-23 BDSX PATIENCE JOHN 10.000 6,1753 500 123,5060 61.753
2021-11-18 BDSX PATIENCE JOHN 9.497 6,3409 475 126,8180 60.220
2021-08-19 BDSX PATIENCE JOHN 8.396 8,0383 420 160,7660 67.490
2021-08-17 BDSX PATIENCE JOHN 1.604 7,1174 80 142,3480 11.416
2020-10-30 BDSX PATIENCE JOHN 30.000 18,0000 1.500 360,0000 540.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BDSX / Biodesix, Inc. Insider Trades
Insidersalg BDSX / Biodesix, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BDSX / Biodesix, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BDSX / Biodesix, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af John Patience som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-07-02 2025-06-30 4 BDSX BIODESIX INC
Common Stock
M - Exercise 22.874 407.486 5,95
2025-04-02 2025-03-31 4 BDSX BIODESIX INC
Common Stock
M - Exercise 46.686 384.612 13,82
2024-12-03 2024-12-03 4 AXDX Accelerate Diagnostics, Inc
Common Stock
P - Purchase 200.000 653.224 44,13 1,57 314.000 1.025.562
2024-11-06 2024-11-05 4 BDSX BIODESIX INC
Common Stock
P - Purchase 75.000 2.153.298 3,61 1,38 103.710 2.977.580
2024-05-23 2024-05-23 4 BDSX BIODESIX INC
Common Stock
M - Exercise 217.400 4.829.611 4,71
2024-01-25 2024-01-23 4 AXDX Accelerate Diagnostics, Inc
Common Stock
P - Purchase 16.666 453.224 3,82
2023-08-07 2023-08-03 4 BDSX BIODESIX INC
Common Stock
A - Award 61.728 4.612.211 1,36 1,62 99.999 7.471.782
2022-11-21 2022-11-21 4 BDSX BIODESIX INC
Common Stock
P - Purchase 1.739.130 4.550.483 61,86 1,15 2.000.000 5.233.055
2022-05-26 2022-05-24 4 BDSX BIODESIX INC
Restricted Stock Units
A - Award 83.333 83.333
2022-04-11 2022-04-07 4 BDSX BIODESIX INC
Common Stock
P - Purchase 279.329 337.926 476,70 1,79 499.999 604.888
2022-01-04 2021-12-30 4 BDSX BIODESIX INC
Common Stock
P - Purchase 22.988 52.988 76,63 4,35 99.998 230.498
2022-01-04 2021-12-30 4 BDSX BIODESIX INC
Common Stock
P - Purchase 137.931 2.078.298 7,11 4,35 600.000 9.040.596
2021-12-10 2021-09-30 4 AXDX Accelerate Diagnostics, Inc
Common Stock
A - Award 21.702 4.365.585 0,50 7,68 166.671 33.527.693
2021-11-24 2021-11-23 4 BDSX BIODESIX INC
Common Stock
P - Purchase 10.000 1.940.367 0,52 6,18 61.753 11.982.348
2021-11-22 2021-11-18 4 BDSX BIODESIX INC
Common Stock
P - Purchase 9.497 1.930.367 0,49 6,34 60.220 12.240.264
2021-08-23 2021-08-19 4 BDSX BIODESIX INC
Common Stock
P - Purchase 8.396 1.920.870 0,44 8,04 67.490 15.440.529
2021-08-19 2021-08-17 4 BDSX BIODESIX INC
Common Stock
P - Purchase 1.604 1.912.474 0,08 7,12 11.416 13.611.842
2021-07-01 2021-06-29 4 BDSX BIODESIX INC
Stock Options (Right to buy)
A - Award 34.385 34.385
2021-05-24 2021-05-20 4 AXDX Accelerate Diagnostics, Inc
Stock Option (right to buy)
A - Award 35.168 35.168
2021-04-13 2021-04-09 4 AXDX Accelerate Diagnostics, Inc
Common Stock
A - Award 21.701 4.343.883 0,50 7,68 166.664 33.361.021
2021-02-23 2021-02-19 4 AXDX Accelerate Diagnostics, Inc
Common Stock
A - Award 21.701 4.322.182 0,50 7,68 166.664 33.194.358
2020-12-09 2020-12-07 4 BDSX BIODESIX INC
Stock Options (Right to Buy)
M - Exercise -23.440 11.718 -66,67
2020-12-09 2020-12-07 4 BDSX BIODESIX INC
Stock Options (Right to Buy)
M - Exercise -35.157 1 -100,00
2020-12-09 2020-12-07 4 BDSX BIODESIX INC
Common Stock
M - Exercise 23.440 58.597 66,67 6,83 160.095 400.218
2020-12-09 2020-12-07 4 BDSX BIODESIX INC
Common Stock
M - Exercise 35.157 35.157 6,83 240.122 240.122
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Series B Preferred Stock
C - Conversion -1.454.545 0 -100,00
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
3% Convertible Debt due June 2021
C - Conversion 0
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
3% Convertible Debt due June 2021
C - Conversion 0
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Series H Preferred Stock
C - Conversion -4.182.413 0 -100,00
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Series G Preferred Stock
C - Conversion -6.711.816 0 -100,00
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Series G Preferred Stock
C - Conversion -957.114 0 -100,00
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Series F Preferred Stock
C - Conversion -3.055.837 0 -100,00
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Series F Preferred Stock
C - Conversion -3.205.681 0 -100,00
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Series E Preferred Stock
C - Conversion -1.484.624 0 -100,00
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Series E Preferred Stock
C - Conversion -809.200 0 -100,00
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Series D Preferred Stock
C - Conversion -2.932.534 0 -100,00
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Series D Preferred Stock
C - Conversion -250.000 0 -100,00
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Series C Preferred Stock
C - Conversion -666.666 0 -100,00
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Series B-1 Preferred Stock
C - Conversion -1.250.000 0 -100,00
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Common Stock
P - Purchase 30.000 30.000 18,00 540.000 540.000
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Common Stock
C - Conversion 64.416 2.811.431 2,34 14,40 927.590 40.484.606
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Common Stock
C - Conversion 81.600 1.910.968 4,46 14,40 1.175.040 27.517.939
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Common Stock
C - Conversion 245.041 2.747.015 9,79
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Common Stock
C - Conversion 2.501.974 2.501.974
2020-11-03 2020-10-30 4 BDSX BIODESIX INC
Common Stock
C - Conversion 1.829.368 1.829.368
2020-11-03 2020-06-23 4 BDSX BIODESIX INC
3% Convertible Debt due June 2021
A - Award 1.150.000
2020-07-31 2020-03-24 4/A AXDX Accelerate Diagnostics, Inc
Common Stock
P - Purchase 5.000 4.300.481 0,12 6,83 34.150 29.372.285
2020-04-03 2020-04-01 4 AXDX Accelerate Diagnostics, Inc
Stock Option (right to buy)
A - Award 13.779 13.779
2020-03-27 2019-04-01 4 AXDX Accelerate Diagnostics, Inc
Stock Option (right to buy)
A - Award 12.290 12.290
2020-03-26 2020-03-24 4 AXDX Accelerate Diagnostics, Inc
Common Stock
P - Purchase 5.000 4.196.211 0,12 6,83 34.150 28.660.121
2018-11-13 2018-11-08 4 AXDX Accelerate Diagnostics, Inc
Common Stock
P - Purchase 10.000 39.411 34,00 14,96 149.600 589.589
2018-05-25 2018-05-23 4 SRCL STERICYCLE INC
Restricted Stock Units
A - Award 1.970 3.878 103,25
2018-05-24 2018-05-23 4 SRCL STERICYCLE INC
Non-Qualified Stock Option (right to buy)
M - Exercise -7.105 0 -100,00
2018-05-24 2018-05-23 4 SRCL STERICYCLE INC
Common Stock
S - Sale -6.624 150.110 -4,23 63,15 -418.281 9.478.891
2018-05-24 2018-05-23 4 SRCL STERICYCLE INC
Common Stock
M - Exercise 7.105 156.734 4,75 58,82 417.916 9.219.094
2018-05-02 2018-04-30 4 SRCL STERICYCLE INC
Restricted Stock Units
A - Award 170 2.078 8,91
2018-04-03 2018-04-01 4 AXDX Accelerate Diagnostics, Inc
Stock Option (right to buy)
A - Award 9.476 9.476
2018-02-01 2018-01-31 4 SRCL STERICYCLE INC
Restricted Stock Units
A - Award 132 1.908 7,43
2017-11-09 2017-11-07 4 AXDX Accelerate Diagnostics, Inc
Common Stock
P - Purchase 20.000 4.191.211 0,48 18,75 375.000 78.585.206
2017-11-08 2017-11-06 4 AXDX Accelerate Diagnostics, Inc
Common Stock
P - Purchase 38.700 4.171.211 0,94 18,61 720.207 77.626.237
2017-11-01 2017-10-31 4 SRCL STERICYCLE INC
Restricted Stock Units
A - Award 141 1.776 8,62
2017-08-01 2017-07-31 4 SRCL STERICYCLE INC
Restricted Stock Units
A - Award 129 1.635 8,57
2017-05-26 2017-05-25 4 SRCL STERICYCLE INC
Restricted Stock Units
M - Exercise -495 0 -100,00
2017-05-26 2017-05-25 4 SRCL STERICYCLE INC
Common Stock
M - Exercise 495 149.629 0,33
2017-05-26 2017-05-24 4 SRCL STERICYCLE INC
Restricted Stock Units
A - Award 1.506 1.506
2017-04-04 2017-04-01 4 AXDX Accelerate Diagnostics, Inc
Stock Option (right to buy)
A - Award 11.721 11.721
2017-01-10 2017-01-09 4 AXDX Accelerate Diagnostics, Inc
Common Stock
P - Purchase 39.500 2.110.662 1,91 19,00 750.500 40.102.578
2017-01-10 2017-01-09 4 AXDX Accelerate Diagnostics, Inc
Common Stock
P - Purchase 13.200 4.132.511 0,32 19,00 250.800 78.517.709
2016-12-14 2016-12-13 4 AXDX Accelerate Diagnostics, Inc
Stock Option (right to buy)
M - Exercise -24.670 0 -100,00
2016-12-14 2016-12-13 4 AXDX Accelerate Diagnostics, Inc
Common Stock
M - Exercise 24.670 44.670 123,35 6,48 159.862 289.462
2016-12-07 2016-12-01 4 AXDX Accelerate Diagnostics, Inc
Stock Option (right to buy)
M - Exercise -20.000 24.670 -44,77
2016-12-07 2016-12-01 4 AXDX Accelerate Diagnostics, Inc
Common Stock
M - Exercise 20.000 20.000 6,48 129.600 129.600
2016-05-31 2016-05-20 4 AXDX Accelerate Diagnostics, Inc
Put Option (obligation to buy)
E - Other -1.000 0 -100,00
2016-05-27 2016-05-25 4 SRCL STERICYCLE INC
Restricted Stock Units
A - Award 495 495
2016-05-27 2016-05-25 4 SRCL STERICYCLE INC
Non-Qualified Stock Option (right to buy)
A - Award 3.713 3.713
2016-04-01 2016-04-01 4 AXDX Accelerate Diagnostics, Inc
Stock Option (right to buy)
A - Award 8.181 74.937 12,26
2016-02-22 2016-02-19 4 AXDX Accelerate Diagnostics, Inc
Put Option (obligation to buy)
S - Sale -1.000 1.000 -50,00 100,00 -100.000 100.000
2016-02-09 2016-02-09 4 AXDX Accelerate Diagnostics, Inc
Common Stock
P - Purchase 50.000 4.119.311 1,23 11,39 569.500 46.918.952
2015-12-17 2015-12-15 4 AXDX Accelerate Diagnostics, Inc
Common Stock
P - Purchase 29.411 29.411 17,00 499.987 499.987
2015-12-14 2015-12-10 4 SRCL STERICYCLE INC
Non-Qualified Stock Option (right to buy)
M - Exercise -10.424 0 -100,00
2015-12-14 2015-12-10 4 SRCL STERICYCLE INC
Non-Qualified Stock Option (right to buy)
M - Exercise -1.248 0 -100,00
2015-12-14 2015-12-10 4 SRCL STERICYCLE INC
Common Stock
M - Exercise 1.248 149.134 0,84 32,88 41.028 4.902.780
2015-12-14 2015-12-10 4 SRCL STERICYCLE INC
Common Stock
M - Exercise 10.424 147.886 7,58 43,33 451.672 6.407.900
2015-05-29 2015-05-27 4 SRCL STERICYCLE INC
Non-Qualified Stock Option (right to buy)
A - Award 4.931 4.931
2015-04-06 2015-04-02 4 AXDX Accelerate Diagnostics, Inc
Stock Option (right to buy)
A - Award 7.658 66.756 12,96
2015-03-18 2015-03-17 4 AXDX] Accelerate Diagnostics, Inc
Common Stock
P - Purchase 2.000 6.140.473 0,03 20,00 40.000 122.809.460
2014-12-11 2014-12-10 4 SRCL STERICYCLE INC
Non-Qualified Stock Option (right to buy)
M - Exercise -6.500 1.248 -83,89 130,63 -849.079 163.023
2014-12-11 2014-12-10 4 SRCL STERICYCLE INC
Non-Qualified Stock Option (right to buy)
M - Exercise -3.624 0 -100,00 130,63 -473.394
2014-12-11 2014-12-10 4 SRCL STERICYCLE INC
Common Stock
S - Sale -55.000 137.462 -28,58 130,77 -7.192.240 17.975.631
2014-12-11 2014-12-10 4 SRCL STERICYCLE INC
Common Stock
S - Sale -3.624 192.462 -1,85 130,63 -473.394 25.140.849
2014-12-11 2014-12-10 4 SRCL STERICYCLE INC
Common Stock
M - Exercise 3.624 196.086 1,88 24,00 86.994 4.707.044
2014-12-11 2014-12-10 4 SRCL STERICYCLE INC
Common Stock
S - Sale -6.500 192.462 -3,27 130,63 -849.079 25.140.849
2014-12-11 2014-12-10 4 SRCL STERICYCLE INC
Common Stock
M - Exercise 6.500 198.962 3,38 32,88 213.688 6.540.876
2014-05-23 2014-05-21 4 SRCL STERICYCLE INC
Non-Qualified Stock Option (right to buy)
A - Award 4.359 4.359
2014-05-02 2014-05-02 4 AXDX Accelerate Diagnostics, Inc
Subscription Rights (right to buy)
X - Other -89.400 0 -100,00
2014-05-02 2014-05-02 4 AXDX Accelerate Diagnostics, Inc
Common Stock
X - Other 89.400 6.227.873 1,46 16,80 1.501.920 104.628.266
2014-04-07 2014-04-03 4 AXDX Accelerate Diagnostics, Inc
Stock Option (right to buy)
A - Award 14.428 59.098 32,30
2013-12-04 2013-12-03 4 SRCL STERICYCLE INC
Non-Qualified Stock Option (right to buy)
M - Exercise -6.000 3.624 -62,34
2013-12-04 2013-12-03 4 SRCL STERICYCLE INC
Common Stock
A - Award 6.000 192.462 3,22 24,00 144.030 4.620.050
2013-10-29 2013-10-28 4 AXDX] Accelerate Diagnostics, Inc
Common Stock
P - Purchase 2.500 6.138.473 0,04 12,73 31.825 78.142.761
2013-10-29 2013-10-28 4 AXDX] Accelerate Diagnostics, Inc
Common Stock
P - Purchase 864 6.135.973 0,01 12,68 10.956 77.804.138
2013-10-29 2013-10-28 4 AXDX] Accelerate Diagnostics, Inc
Common Stock
P - Purchase 50 6.135.109 0,00 12,66 633 77.670.480
2013-10-29 2013-10-28 4 AXDX] Accelerate Diagnostics, Inc
Common Stock
P - Purchase 1.000 6.135.059 0,02 12,63 12.630 77.485.795
2013-10-29 2013-10-28 4 AXDX] Accelerate Diagnostics, Inc
Common Stock
P - Purchase 2.000 6.134.059 0,03 12,62 25.240 77.411.825
2013-10-29 2013-10-28 4 AXDX] Accelerate Diagnostics, Inc
Common Stock
P - Purchase 400 6.132.059 0,01 12,58 5.032 77.141.302
2013-10-29 2013-10-28 4 AXDX] Accelerate Diagnostics, Inc
Common Stock
P - Purchase 350 6.131.659 0,01 12,57 4.400 77.074.954
2013-10-29 2013-10-28 4 AXDX] Accelerate Diagnostics, Inc
Common Stock
P - Purchase 27 6.131.309 0,00 12,56 339 77.009.241
2013-08-13 2013-08-12 4 AXDX Accelerate Diagnostics, Inc
Subscription Rights (right to buy)
O - Other -367.179 0 -100,00
2013-08-13 2013-08-12 4 AXDX Accelerate Diagnostics, Inc
Common Stock
O - Other 397.494 6.131.282 6,93 8,04 3.195.852 49.295.507
2013-06-10 2013-06-07 4 SRCL STERICYCLE INC
Common Stock
S - Sale -18.000 186.462 -8,80 108,18 -1.947.240 20.171.459
2013-06-10 2013-06-07 4 SRCL STERICYCLE INC
Common Stock
S - Sale -27.500 204.462 -11,86 108,22 -2.976.050 22.126.878
2013-05-22 2013-05-21 4 SRCL STERICYCLE INC
Non-Qualified Stock Option (right to buy)
A - Award 5.245 5.245
2013-04-05 2013-04-03 4 AXDX Accelerate Diagnostics, Inc
Stock Option (right to buy)
A - Award 44.670 44.670
2013-03-08 2013-03-06 4 AXDX Accelerate Diagnostics, Inc
Warrants (right to buy)
J - Other -571.160 0 -100,00
2013-03-08 2013-03-06 4 AXDX Accelerate Diagnostics, Inc
Warrants (right to buy)
X - Other -6.428.840 571.160 -91,84
2013-03-08 2013-03-06 4 AXDX Accelerate Diagnostics, Inc
Warrants (right to buy)
X - Other -7.000.000 7.000.000 -50,00
2013-03-08 2013-03-06 4 AXDX Accelerate Diagnostics, Inc
Common Stock
J - Other 5.733.788 5.733.788
2013-03-08 2013-03-06 4 AXDX Accelerate Diagnostics, Inc
Common Stock
J - Other -14.000.000 0 -100,00
2013-03-08 2013-03-06 4 AXDX Accelerate Diagnostics, Inc
Common Stock
J - Other -13.428.840 14.000.000 -48,96
2013-03-08 2013-03-06 4 AXDX Accelerate Diagnostics, Inc
Common Stock
X - Other 6.428.840 27.428.840 30,61 2,00 12.857.680 54.857.680
2013-03-08 2013-03-06 4 AXDX Accelerate Diagnostics, Inc
Common Stock
X - Other 7.000.000 21.000.000 50,00 1,03 7.210.000 21.630.000
2012-11-28 2012-11-27 4 SRCL STERICYCLE INC
Non-Qualified Stock Option (right to buy)
M - Exercise -8.726 0 -100,00
2012-11-28 2012-11-27 4 SRCL STERICYCLE INC
Director Stock Option (right to buy)
M - Exercise -10.472 0 -100,00
2012-11-28 2012-11-27 4 SRCL STERICYCLE INC
Common Stock
S - Sale -8.726 231.962 -3,63 92,89 -810.558 21.546.950
2012-11-28 2012-11-27 4 SRCL STERICYCLE INC
Common Stock
M - Exercise 8.726 240.688 3,76 23,54 205.366 5.664.592
2012-11-28 2012-11-27 4 SRCL STERICYCLE INC
Common Stock
S - Sale -10.472 231.962 -4,32 92,89 -972.744 21.546.950
2012-11-28 2012-11-27 4 SRCL STERICYCLE INC
Common Stock
M - Exercise 10.472 242.434 4,51 20,50 214.676 4.969.897
2012-11-28 2012-11-26 4 SRCL STERICYCLE INC
Director Stock Option (right to buy)
M - Exercise -1.150 10.472 -9,90
2012-11-28 2012-11-26 4 SRCL STERICYCLE INC
Common Stock
S - Sale -1.150 231.962 -0,49 92,51 -106.386 21.458.805
2012-11-28 2012-11-26 4 SRCL STERICYCLE INC
Common Stock
M - Exercise 1.150 233.112 0,50 20,50 23.575 4.778.796
2012-07-03 2012-06-26 4 AXK ACCELR8 TECHNOLOGY CORP
Warrants (right to buy)
P - Purchase 7.000.000 14.000.000 100,00
2012-07-03 2012-06-26 4 AXK ACCELR8 TECHNOLOGY CORP
Warrants (right to buy)
P - Purchase 7.000.000 14.000.000 100,00
2012-07-03 2012-06-26 4 AXK ACCELR8 TECHNOLOGY CORP
Common Stock
P - Purchase 14.000.000 14.000.000 1,03 14.420.000 14.420.000
2012-07-03 3 AXK ACCELR8 TECHNOLOGY CORP
Common Stock
14.000.000
2012-05-23 2012-05-22 4 SRCL STERICYCLE INC
Non-Qualified Stock Option (right to buy)
A - Award 5.960 5.960
2012-03-19 2012-03-16 4 SRCL STERICYCLE INC
Common Stock
S - Sale -4.182 231.962 -1,77 86,50 -361.745 20.064.829
2012-03-19 2012-03-15 4 SRCL STERICYCLE INC
Common Stock
S - Sale -540 236.144 -0,23 86,47 -46.691 20.418.262
2012-03-15 2012-03-15 4 SRCL STERICYCLE INC
common stock
S - Sale 12.178 236.144 5,44 86,47 1.052.974 20.418.262
2012-03-15 2012-03-14 4 SRCL STERICYCLE INC
common stock
S - Sale -684 248.862 -0,27 87,79 -60.051 21.848.590
2012-03-15 2012-03-13 4 SRCL STERICYCLE INC
common stock
S - Sale -39.416 249.546 -13,64 87,58 -3.452.195 21.856.137
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)